Works matching IS 00912700 AND DT 2022 AND VI 62 AND IP 4

Results: 13

Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID‐19‐Associated Acute Respiratory Distress Syndrome.

Published in:

2022

By:

Shudofsky, Kimberly N.;
Janssen, Paddy K. C.;
Foudraine, Norbert;
le Noble, Jos L. M. L.

Publication type:

Letter to the Editor

Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 449, doi. 10.1002/jcph.1999

By:

Smith, Kathryn;
Wang, Michelle;
Abdukalikov, Ruslan;
McAullife, Amy;
Whitesell, Dena;
Richard, Janelle;
Sauer, William;
Quaye, Aurora

Publication type:

Article

Pharmacokinetics of Tropifexor, a Potent Farnesoid X Receptor Agonist, in Participants With Varying Degrees of Hepatic Impairment.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 520, doi. 10.1002/jcph.1996

By:

Chen, Jin;
Gu, Jessie;
Shah, Bharti;
Stringer, Rowan;
Reis da Silva Torrao, Leonel;
Hackling, Melissa;
Nidamarthy, Prasanna Kumar;
Prince, William T.;
Woessner, Ralph

Publication type:

Article

MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 463, doi. 10.1002/jcph.1995

By:

Smith, Kimberly W.;
Sicignano, Dakota J.;
Hernandez, Adrian V.;
White, C. Michael

Publication type:

Article

Population Pharmacokinetics of Ponatinib in Healthy Adult Volunteers and Patients With Hematologic Malignancies and Model‐Informed Dose Selection for Pediatric Development.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 555, doi. 10.1002/jcph.1990

By:

Hanley, Michael J.;
Diderichsen, Paul M.;
Narasimhan, Narayana;
Srivastava, Shouryadeep;
Gupta, Neeraj;
Venkatakrishnan, Karthik

Publication type:

Article

Predicted Cardiac Functional Responses to Renal Actions of SGLT2i in the DAPACARD Trial Population: A Mathematical Modeling Analysis.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 541, doi. 10.1002/jcph.1987

By:

Yu, Hongtao;
Basu, Sanchita;
Tang, Weifeng;
Penland, Robert C.;
Greasley, Peter J.;
Oscarsson, Jan;
Boulton, David W.;
Hallow, K. Melissa

Publication type:

Article

Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 532, doi. 10.1002/jcph.1984

By:

Peer, Cody J.;
Heiss, Brian L.;
Goldstein, Daniel A.;
Goodell, Jennifer C.;
Figg, William D.;
Ratain, Mark J.

Publication type:

Article

Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its Metabolites.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 505, doi. 10.1002/jcph.1980

By:

Wang, Ellen Q.;
Le, Vu;
Winton, Jennifer A.;
Tripathy, Sakambari;
Raje, Sangeeta;
Wang, Lisy;
Dowty, Martin E.;
Malhotra, Bimal K.

Publication type:

Article

Time Above All Else: Pharmacodynamic Analysis of β‐Lactams in Critically Ill Patients.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 479, doi. 10.1002/jcph.1977

By:

Landmesser, Katie B.;
Clark, Justin A.;
Burgess, David S.

Publication type:

Article

Long‐Acting Lipoglycopeptides Can Interfere With Vancomycin Therapeutic Drug Monitoring.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 472, doi. 10.1002/jcph.1975

By:

Smelter, Dan F.;
Trisler, Michael J.;
McCreary, Erin K.;
Baker, Matthew;
Copeland, Kenneth;
Dilworth, Thomas J.;
Rose, Warren E.

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 443, doi. 10.1002/jcph.1660
Publication type:: Article

Assessment of Transporter‐Mediated Drug Interactions for Enasidenib Based on a Cocktail Study in Patients With Relapse or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 494, doi. 10.1002/jcph.1979

By:

Cheng, Yiming;
Wang, Xiaomin;
Tong, Zeen;
Reyes, Josephine;
Carayannopoulos, Leon;
Zhou, Simon;
Li, Yan

Publication type:

Article

Racial and Ethnic Differences in Drug Disposition and Response: Review of New Molecular Entities Approved Between 2014 and 2019.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 4, p. 486, doi. 10.1002/jcph.1978

By:

Ramamoorthy, Anuradha;
Kim, Hannah H.;
Shah‐Williams, Ebony;
Zhang, Lei

Publication type:

Article